Westat’s data science and multicenter approach enables clients to make groundbreaking medical advances to prevent, diagnose, and treat communicable and noncommunicable diseases. For decades, our commitment has remained unchanged: use our research expertise to protect and improve the public’s health.
Pandemics. Opioid overdoses. Diabetes. Obesity. Depression. These are among the top public health challenges that influence the research of our premier interdisciplinary public health professionals and epidemiologists. Fueled by our evidence-based research approach on preventing, diagnosing, and treating infectious and chronic diseases and other conditions, Westat works to support our clients in finding ways to determine how best to protect and improve the health of affected populations and society at large. Our research enables our clients to make revolutionary medical advances—developing and tracking the effectiveness of new vaccines, therapies, and medicines for a healthier world. Westat provides expertise in surveillance, program interventions, communication, and evaluation. We apply our knowledge, continually demonstrating our ability to quickly adjust to unforeseen research challenges and our commitment to absolute transparency.
Coordinating centers are a key part of multicenter research initiatives; they’re centralized hubs that pool complex biomedical and administrative data from multiple research centers, then aggregate, manage, and analyze the data, and finally make the data accessible to researchers. Our management of National Institutes of Health (NIH) coordinating centers helps collate public health data to provide insights on a range of issues. These data have revealed how disparities in maternal health outcomes can be reduced, how environmental exposures affect human health over a lifetime, what research programs reduce HIV incidence rates in at-risk youth, and the effects of SARS-CoV-2 on community transmission and the blood supply. They have expanded the knowledge base on tobacco regulatory science, advanced evidence-based care to improve outcomes for persons with early psychosis, and so much more.
Westat is committed to using our expertise in epidemiology, statistics, and public health to strengthen disease surveillance. Our efforts to monitor trends, identify sentinel events, and track key metrics provide decisionmakers with critical situational awareness. Partnering with federal and state agencies in fields ranging from infectious disease to substance abuse, we apply rigorous methodology to both traditional and innovative data collection and analysis, generating timely insights to support public health action.
What motivates people to improve their health? We employ a research-driven communications framework to create targeted messaging and successful campaigns to influence people to change their health behaviors. Our social marketing strategy and outreach plans, guided by data and best practices, include digital strategies, traditional and social media, partnership engagement, knowledge transfer, website and app development, and multimedia and data visualization.
COVID-19, monkeypox, Zika, and HIV are prime examples of how easily contagious diseases spread, with devastating impact on society, while nontransmissible conditions such as cancer, heart disease, and diabetes continue to be among the world’s most concerning health problems. We apply our expertise in health research to disrupt the impact of illness and contribute to a healthier world. Our research provides data that inform on many urgent issues, including how to reduce global HIV transmissions and improve treatment, and what services support international research on preventing and managing chronic diseases. We have delivered findings on how best to strengthen cancer research across Latin America and how to build a rapid research response capability to address emerging threats to the blood supply during pandemics.
Meet the Team
National Heart, Lung, and Blood InstituteHow does community engagement through CETAC help improve health equity?
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)How does our support for clinical trials reduce new HIV infections and improve care for young people?
Deep Dive with Our Experts
Journal ArticleHealth-related quality of life in children and adolescents with pleuropulmonary blastoma: A report from the International PPB/DICER1 Registry
Pediatric Blood and Cancer
A.T. Nelson, A. Dybvik, P. Mallinger, S.W. McQuaid, D. Watson, L.A. Harney, D.R. Stewart, L.P. Dehner, Y.H. Messinger, A.S. Kunin-Batson, K.A.P. SchultzSOURCE
Journal ArticleManhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline results and costs of a cluster-randomized trial
American Journal of Ophthalmology
L.A. Hark, J.D. Horowitz, P. Gorroochurn, L. Park, Q. Wang, D.F. Diamond, N. Harizman, J.D. Auran, S.C. Maruri, D.R. Henriquez, J. Carrion, R.S.M. Muhire, Y.S. Kresch, L.T. Pizzi, E. Jutkowitz, Saloni Sapru, T. Sharma, C.G. De Moraes, D.S. Friedman, J.M. Liebmann, G.A. C
Journal ArticleSARS-CoV-2 wastewater concentration and linked longitudinal seroprevalence: A spatial analysis of strain mutation, post-COVID-19 vaccination effect, and hospitalization burden forecasting
R.H. Holm, G.A. Rempala, B. Choi, J. Michael Brick, A.R. Amraotkar, R.J. Keith, E.C. Rouchka, J.H. Chariker, K.E. Palmer, T. Smith, A. Bhatnagar